(2R)-2-{[(tert-butoxy)carbonyl]amino}-3-(pyridin-2-yl)propanoic acid → Nalpha-[N-t-butoxycarbonyl-3-(2-pyridyl)-D-alanyl](alphaR,betaR)-5-chloro-1-ethyl-beta-methyltryptophan methyl ester

HRID 1382253Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1382253
[CH3:1][O:2][C:3](=[O:20])[C@@H:4]([C@H:6]([CH3:19])[C:7]1[C:15]2[C:10](=[CH:11][CH:12]=[C:13]([Cl:16])[CH:14]=2)[N:9]([CH2:17][CH3:18])[CH:8]=1)[NH2:5].[C:21]([O:25][C:26]([NH:28][C@@H:29]([C:37](O)=[O:38])[CH2:30][C:31]1[CH:36]=[CH:35][CH:34]=[CH:33][N:32]=1)=[O:27])([CH3:24])([CH3:23])[CH3:22]>C(Cl)Cl>[CH3:1][O:2][C:3](=[O:20])[C@@H:4]([C@H:6]([CH3:19])[C:7]1[C:15]2[C:10](=[CH:11][CH:12]=[C:13]([Cl:16])[CH:14]=2)[N:9]([CH2:17][CH3:18])[CH:8]=1)[NH:5][C:37](=[O:38])[C@@H:29]([CH2:30][C:31]1[CH:36]=[CH:35][CH:34]=[CH:33][N:32]=1)[NH:28][C:26]([O:25][C:21]([CH3:24])([CH3:22])[CH3:23])=[O:27]

Komponenten

4

Edukt 2

HCID 7019139(2R)-2-{[(tert-butoxy)carbonyl]amino}-3-(pyridin-2-yl)propanoic acidHCID 14152057(alphaR,betaR)-5-chloro-1-ethyl-beta-methyltryptophan methyl ester

Produkt 1

HCID 22841453Nalpha-[N-t-butoxycarbonyl-3-(2-pyridyl)-D-alanyl](alphaR,betaR)-5-chloro-1-ethyl-beta-methyltryptophan methyl esterAusbeute 100,3 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6344DichloromethaneLösungsmittel2×

Versuchsvorschrift

To a solution of (αR,βR)-5-chloro-1-ethyl-β-methyltryptophan methyl ester (1.24 g) and N-t-butoxycarbonyl-3-(2-pyridyl)-D-alanine (1.12 g) in dry methylene chloride (30 ml) which was cooled on an ice bath, was added a solution of N,Nα-dicyclohexylcarbodiimide (0.9 g) in dry methylene chloride (5 ml). The mixture was stirred overnight at room temperature. After removal of the solvent, the crude residue was taken up with a mixture of ethyl acetate and water, filtered, and the organic layer was washed with saturated sodium bicarbonate solution, dried over magnesium sulfate, and solvent was evaporated off to give Nα -[N-t-butoxycarbonyl-3-(2-pyridyl)-D-alanyl](αR,βR)-5-chloro-1-ethyl-β-methyltryptophan methyl ester (2.29 g). To this compound was added trifluoroacetic acid (10 ml) and the mixture was stirred for 30 minutes on an ice bath. After evaporation of the solvent, the crude residue was dissolved in chloroform (50 ml), washed with saturated sodium bicarbonate solution, treated with active charcoal, dried over magnesium sulfate, and the solvent was evaporated off to give an oil (1.43 g). The crude material was dissolved in ethanol (10 ml) and saturated alcoholic ammonia (10 ml) was added. The resulting mixture was allowed to stand for 3 days at room temperature and concentrated in vacuo. The crude residue was chromatographed on silica gel (70 g) (chloroform and 50:1 mixture of chloroform and methanol as eluent) to give an oil (0.56 g) which was crystallized from ethanol to afford (3R,6R)-3-[(R)-1-(5-chloro-1-ethylindol-3-yl)ethyl]-6-(2-pyridylmethyl)piperazine-2,5-dione (0.34 g).

Aufarbeitung

  1. customAfter removal of the solvent
  2. additionthe crude residue was taken up with a mixture of ethyl acetate and water
  3. filtrationfiltered
  4. washthe organic layer was washed with saturated sodium bicarbonate solution
  5. dry with materialdried over magnesium sulfate, and solvent
  6. customwas evaporated off

Quellen und Nachweise

ORD-Eintrag
ord-476a45712e4d4e7a95e3339df51978eb
Quelldatensatz
uspto-grants-1989_02
Patentnummer
US04806538

Notizen zur Reaktion

Wird geladen…